These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36624155)

  • 1. Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy.
    Wang C; Chen Q; Chen M; Guo S; Hou P; Zou Y; Wang J; He B; Zhang Q; Chen L; Luo L
    Cancer Immunol Immunother; 2023 Jun; 72(6):1685-1698. PubMed ID: 36624155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia/macrophages.
    Chen T; Liu J; Wang C; Wang Z; Zhou J; Lin J; Mao J; Pan T; Wang J; Xu H; He X; Wu D; Liu Z
    J Immunother Cancer; 2024 Aug; 12(8):. PubMed ID: 39142719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin, activation, and targeted therapy of glioma-associated macrophages.
    Xu C; Xiao M; Li X; Xin L; Song J; Zhan Q; Wang C; Zhang Q; Yuan X; Tan Y; Fang C
    Front Immunol; 2022; 13():974996. PubMed ID: 36275720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy.
    Lin C; Wang N; Xu C
    Front Immunol; 2023; 14():1123853. PubMed ID: 36969167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
    Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
    Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression.
    He X; Guo Y; Yu C; Zhang H; Wang S
    Front Immunol; 2023; 14():1097880. PubMed ID: 36969175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
    Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extract of Astragali Radix and Solanum nigrum Linne regulates microglia and macrophage polarization and inhibits the growth and infiltration of C6 glioblastoma.
    Shen M; Liu S; Wei Q; Zhang X; Wen S; Qiu R; Li Y; Fan H
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117067. PubMed ID: 37619857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
    Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
    Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
    [No Abstract]   [Full Text] [Related]  

  • 12. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma.
    Wang XP; Guo W; Chen YF; Hong C; Ji J; Zhang XY; Dong YF; Sun XL
    Int Immunopharmacol; 2024 May; 133():112074. PubMed ID: 38615383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The controversial role of microglia in malignant gliomas.
    Wei J; Gabrusiewicz K; Heimberger A
    Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
    Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression.
    Miyauchi JT; Chen D; Choi M; Nissen JC; Shroyer KR; Djordevic S; Zachary IC; Selwood D; Tsirka SE
    Oncotarget; 2016 Mar; 7(9):9801-14. PubMed ID: 26755653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
    Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB
    Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells.
    Miyazaki T; Ishikawa E; Matsuda M; Sugii N; Kohzuki H; Akutsu H; Sakamoto N; Takano S; Matsumura A
    Brain Tumor Pathol; 2020 Apr; 37(2):41-49. PubMed ID: 31980975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.